Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Propranolol in acute intermittent porphyria.

A S Menawat, R B Panwar, D K Kochar

    Postgraduate Medical Journal
    |September 1, 1979
    PubMed
    Summary

    This study found that propranolol effectively managed cardiovascular issues like tachycardia and hypertension in patients with acute intermittent porphyria. Lower doses at follow-up maintained normal vital signs and prevented future attacks.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Multimodality evoked potentials in patients of heatstroke.

    Neurology India·2018
    Same author

    Cerebellar ataxia in patients of falciparum malaria.

    Neurology India·2018
    Same author

    Psychiatric Aspects of Skin Diseases.

    Indian journal of dermatology, venereology and leprology·2017
    Same author

    Ehlers-danlos Syndrome in Four Generations.

    Indian journal of dermatology, venereology and leprology·2017
    Same author

    A prospective study on adult patients of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed infection from Bikaner, northwest India.

    Journal of vector borne diseases·2014
    Same author

    Retinal haemorrhage: an unusual presentation of vivax malaria.

    Journal of vector borne diseases·2014

    Area of Science:

    • Cardiology
    • Neurology
    • Pharmacology

    Background:

    • Acute intermittent porphyria (AIP) is a rare genetic disorder.
    • Cardiovascular manifestations, including tachycardia and hypertension, are common during AIP acute phases.
    • Effective management of these cardiovascular symptoms is crucial for patient outcomes.

    Purpose of the Study:

    • To investigate the efficacy of propranolol in managing cardiovascular manifestations in patients with acute intermittent porphyria.
    • To assess the long-term effects of propranolol on heart rate, blood pressure, and AIP attack prevention.

    Main Methods:

    • A study of twenty AIP cases during the acute phase.
    • Administration of propranolol (20-200 mg) to all patients.
    • Monitoring of cardiovascular parameters (heart rate, blood pressure) and AIP attack frequency.

    Main Results:

    • All twenty cases exhibited cardiovascular manifestations, with 100% experiencing tachycardia and 85% experiencing hypertension.
    • Propranolol effectively controlled both tachycardia and hypertension in all patients.
    • Smaller maintenance doses of propranolol at follow-up normalized pulse rate and blood pressure and prevented acute AIP attacks.

    Conclusions:

    • Propranolol is an effective treatment for managing acute cardiovascular complications in acute intermittent porphyria.
    • Long-term, low-dose propranolol therapy can maintain cardiovascular stability and reduce the recurrence of AIP attacks.

    Related Experiment Videos